Bathi saben saham sajrone rolas wulan pungkasan: Y-mAbs Therapeutics Inc (YMAB)
Y-mAbs Therapeutics (YMAB) combines powerful scientific and technical potential in pediatric oncology radioimmunotherapy with the commercialization of precision antibodies to combat metastases. The current level of rolling earnings per share visualizes this balance, where -0.49 expresses the metric's value today. The biotech's financial stability is supported by steady revenue from the sale of Danyelza, which creates a reliable cash flow driven by niche demand.
Rincian analitis perusahaan Y-mAbs Therapeutics
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Y-mAbs Therapeutics|YMAB - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas ymabs.com|YMAB - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Y-mAbs Therapeutics Inc|YMAB - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Y-mAbs Therapeutics|Likuiditas cepet ymabs.com
- indikator pendapatan resik lan kelipatan nilai:
YMAB - Asil keuangan resik|Bathi mangsa ngarep Y-mAbs Therapeutics|YMAB - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Y-mAbs Therapeutics, Inc.|YMAB - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Y-mAbs Corp|YMAB - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Y-mAbs Therapeutics|YMAB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ymabs.com|YMAB - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Y-mAbs Therapeutics
- data pendapatan lan penerimaan dodolan:
Analisis wiwitan perusahaan:ymabs.com (YMAB)
Trailing twelve-month earnings per share (EPS TTM) reflects the portion of total income attributable to a single security, allowing investors to assess the actual return on equity without accounting for dilution. By analyzing the earnings per share over the last 12 months, one can determine how effectively Y-mAbs Therapeutics (YMAB) monetizes its orphan drug patents, despite high production costs and the logistical complexities associated with pediatric oncology.
Pesaing Y-mAbs Therapeutics (YMAB)
ONC - Bathi saben saham sajrone rolas wulan pungkasan|HALO - Bathi resik saben saham (EPS TTM)|RevMed (RVMD) - Bathi saben saham sajrone rolas wulan pungkasan|Ascentage - Bathi saben saham sajroning taun lumaku|CGON (CG Oncology Inc) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan UroGen Pharma URGN|Bathi resik saben saham (EPS TTM) BCAX|PSNL: Bathi saben siji saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Erasca Corp ERAS|Delcath Corp (DCTH) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|AURA - Bathi saben saham sajrone rolas wulan pungkasan|CADL (candeltx.com) - Bathi saben saham sajrone 12 wulan pungkasan|ARAY (accuray.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|SELLAS Life Sciences Group Inc. (SLS) - Bathi resik saben saham (EPS TTM)|ACTU (Actuate Therapeutics Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Citius Oncology Inc|Bathi resik saben saham (EPS TTM) HURA|TARA (Protara Therapeutics) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) FATE (Fate Therapeutics)|Bathi resik saben saham sajrone patang kuartal pungkasan Aadi Bioscience Inc (WHWK)|TScan Therapeutics, Inc. - Bathi resik saben saham (EPS TTM)|CSBR (Champions Oncology, Inc.) - Bathi saben saham sajrone 12 wulan pungkasan|XBIT (XBiotech USA) - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan CEL-SCI Corp (CVM)|OSTX (OS Therapies Inc.) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Radiopharm Theranostics (RADX)|Bathi resik saben saham sajrone 12 wulan pungkasan ARTV (Artiva Biotherapeutics, Inc.)|ANL - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Veru Inc. VERU|Bathi saben saham sajroning taun lumaku TPST|XLO: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan Renovaro RENB|MURA (muraloncology.com) - Bathi resik saben saham sajrone 12 wulan pungkasan|Kairos Pharma Inc - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan OKUR|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytoMed Therapeutics Limited GDTC|Bathi resik saben saham (EPS TTM) CRIS|Bathi resik saben saham (EPS TTM) Apollomics Inc. (APLM)|Bathi resik saben saham (EPS TTM) THAR (Tharimmune Corp)|Bathi resik saben saham sajrone patang kuartal pungkasan Advanced Biomed Inc (ADVB)|Genprex Inc - Bathi resik saben saham (EPS TTM)|CLDI - Bathi resik saben saham (EPS TTM)|Sunshine Biopharma Inc. (SBFM) - Bathi saben saham sajrone rolas wulan pungkasan|XBIO - Bathi resik saben saham sajrone patang kuartal pungkasan|SLRX (Salarius Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) Kitov Pharma|Bathi resik saben saham sajrone 12 wulan pungkasan AONC (American Oncology Network)|BGNE - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi resik saben saham (EPS TTM) CKPT (Checkpoint Therapeutics Inc.)|Elevation Oncology, Inc. - Bathi saben saham sajrone rolas wulan pungkasan|ICAD - Bathi saben saham sajrone rolas wulan pungkasan|IKNA - Bathi resik saben saham (EPS TTM)|Notable Labs (NTBL) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan VIRX|MOR (MorphoSys Corporation) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NAYA Biosciences Inc NAYA|Bathi saben saham sajrone rolas wulan pungkasan Ascentage Pharma (AAPGV)
